New Global Pooled Analysis Supports Clinical Utility of Circul...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., December 9, 2020, /PRNewswire-AsiaNet/-- Menarini Silicon Biosystems [http://www.siliconbiosystems.com/ ], a pioneer of liquid biopsy technology, today announced the results of a pooled analysis of 14 clinical trials on the relevance of circulating tumor cell (CTC) count to predict both ...
Authors: LATEST ASIANET NEWS RELEASES